//
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar
Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses
Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology
Biological Versus Chronological Aging: JACC Focus Seminar
Adenosine and adenosine receptor-mediated action in coronary microcirculation